Engagement of major histocompatibility complex class II molecules induces sustained, lymphocyte function-associated molecule 1-dependent cell adhesion by unknown
C
ognate recognition of APC by antigen-specific T cells
is critically dependent on adhesive interactions medi-
ated by LFA1 molecules present on both T cells and APC
(1) . While LFA-1 is constitutively expressed on lymphocytes,
its adhesion function is activated after antigen-specific recog-
nition (2) . Engagement of the TCR by mAbs was recently
shown to upregulate the affinity of LFA-1 for its counter
receptors (3, 4) . This proceeds via intracellular signaling mech-
anisms that involve the activation of protein kinaseC (PKC) .
We demonstrate here that Ia molecules can similarly trans-
duce intracellular signals that activate LFA-1 molecules on
Ia+ cells.
Materials and Methods
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Summary
Antigenic stimulation is associated with enhanced adhesion between T cells and antigen-presenting
cells (APC) . Binding of ligands to the T cell antigen receptor activates the adhesion function
of lymphocyte function-associated molecule 1 (LFA1 ; CD11a/CD18) . We demonstrate here that
ligand binding to major histocompatibility complex class II (Ia) molecules also activates LFA-1
function, providing a reciprocal mechanism for the induction of adhesion between T cells and
Ia+ APC . Adhesion was affected by a qualitative change in LFA1 molecules and was reversed
by the protein kinase C inhibitor sphingosine. These results define a novel role for la molecules
as signal transducing receptors that regulateLFA1-dependent adhesion via a putative, Ia-coupled
protein kinase(s) .
Reagents andAntibodies.
￿
Toxic shock syndrome toxin 1(TSST 1)
and Staphylococcal exotoxin B (SEB) were obtained from Toxin
Technology (Madison, WI) . mAb ST259 was kindly provided by
Dr. E . Yunis (Dana Farber Cancer Institute, Boston, MA) . mAb
L243, directed against monomorphic determinants on human
HLA-DR molecules, was generated from hybridoma cells (Amer-
ican Type Culture Collection, Bethesda,MD) . Anti-LFA-la chain
mAb IOT16, anti-LFA10 chain mAb IOT18, and anti-ICAM-1
mAb 84H10 were allobtained fromAMAC, Inc. (Westbrook,ME) .
Sphinghosine, ceramide, BSA, and PMA were obtained from Sigma
Chemical Co . (St . Louis, MO) .
Cells.
￿
High density tonsillar human B cells and resting human
T cells were isolated as described (5) . Activated T cells were pre-
pared by stimulating resting T cells with PHA for 5 d, followed
by stimulation with IL2 at 10 U/ml for an additional 5 d . EBV
transformed lymphoblastoid B cell lines were derived from normal
donors and from an immunodeficient patient with absent Ia ex-
pression . Monocytes were prepared as described (6) .
Aggregation Assays.
￿
Cells were resuspended inRPMI 1640 and
seeded in 96-well microtiter plates at 2 x 101 cells/well for B cells,
monocytes, and T cells, and at 5 x 10 4 for lymphoblastoid B cell
lines. Cells were stimulated at 37°C for the indicated time periods
with TSST-1 at 1 Fig/ml ; SEB at 10 Rg/ml ; Fab mAb L243 at 1
t~g/ml ; Fab mAb ST2-59 at 1 hg/ml, or withPMA at 25 ug/ml .
Cell aggregation was monitored using light microscopy by counting
the number of cell aggregates containing 310 cells per well (7) .
Values are means of scores of two wells ± SD, and the data are
representative of three other experiments .
Results and Discussion
Fig . 1 A demonstrates that Staphylococcus TSST1, which
binds to Ia molecules (8), induces the aggregation of la'
human tonsilar B cells. Aggregation was evident by 15 min
post-stimulation, involved >80% of the cells in culture by
4 h, and was sustained for at least 12 h. Identical aggregation
was obtained with the Fab fragment of mAb L243, which
recognizes an epitope on HLA-DR closely related to the
TSST-1 binding site (8) . Aggregation induced by TSST1 and
by mAb L243 was similar in magnitude to that induced by
the PKC activator PMA, which affects sustained activation
of LFA-1 adhesion function (3, 9) . Two ligands that bind
to epitopes distinct from those recognized by TSST-1 and by
mAb L243, namely SEB and the Fab fragment of the anti-
HLADR/DQ mAb ST2-59 (8, 10), failed to induce B cell
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￿
Induction of leukocyte adhesion by la-binding ligands . (A)
Photomicrographs oftonsillar humanB cells treated for 4 h with medium
alone or with TSST1 . (B) Time course of aggregation of tonsillar B cells
induced by Ia-binding ligands. (C) la-binding ligands induce the aggrega-
tion of la+ but not of la- leukocytes. (C) Resting T cells and mono-
cytes were stimulated for 4 h while activated T cells and B lymphoblastoid
cell lines were stimulated for 1 h .
aggregation . Thus, induction of adhesion via Ia is restricted
by the epitope specificity of the binding ligands .
TSST1 and mAb L243 induced the aggregation of other
Ia' leukocytes, including activated T cells, monocytes, and
B lymphoblastoid lines . The requirement for la surface ex-
pression for the induction of cell aggregation by TSST1 and
mAb L243 was demonstrated by the failure of both ligands
to induce the aggregation of resting T cells, which do not
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express la molecules on their surface, or of B lymphoblastoid
cells derived from a patient with congenital absence ofIa ex-
pression (11) (Fig. 1 C) .
Adhesion induced by Ia-binding ligands was mediated by
LFA1 and its counter receptors. mAbs to either the a chain
or the0 chain ofthe LFA-1 heterodimer inhibited cell aggre-
gation induced by TSST1 or by mAbs L243 (Fig . 2 A), as
well as by PMA, as previously noted (9) . In addition, a mAb
directed against intercellular adhesion molecule 1(ICAM-1),
a counter receptor for LFA1(12), partially inhibited cell aggre-
gation induced byTSST1 and bymAb L243 (Fig . 2A) . The
more effective inhibition of cell aggregation by anti-LFA-1
mAbs compared with anti-ICAM-1mAb suggests that other
LFA1 counter receptors, such as ICAM-2 (13), play a role
in la-triggered adhesion . la-mediated adhesion was less
Figure 2 .
￿
Induction ofadhesion via Ia molecules is mediated by LFA-1
and its counter receptors. (A) Inhibition of aggregation of high density
tonsillar B cells byanti-LFA-lachain mAb, anti-LFA 1/3 chain mAb, anti-
ICAM-1 mAb, and by a control mAb, ST2-59 . All mAbs were added at
a final concentration of25 kg/ml. (B) Induction of adhesion in monocyte
and B lymphocyte-enriched preparations ofPBMC from a normal donor
or from apatientwith leukocyte adhesion deficiency.PBMC were enriched
for monocytes and B cells by rosetting with SRBC and collecting the non-
rosetting fraction, as described (5). (A and B) Cells were treated for 4
h with theindicated stimulus, as described for Fig. 1 . Results are represen-
tative of a total of three experiments for A and two experiments for B .
Lymphocyte Function-associated Molecule 1Figure 3 .
￿
Ia ligands induce cell aggregation by activating the adhesion
function ofLFA-1 and not that ofits counter receptors . T cell lines derived
from a normal donor [NL], from a leukocyte adhesion deficiency patient
[LFA-1(-)], or from an la-deficient patient [Ia(-)] were propagated with
PHA, IIT2, and irradiated allogeneic feeder cells as described (17) . All three
lines expressed comparable levels of ICAM-1 and, when applicable, com-
parable levels ofLFA-1 and Ia . Homogenous cell populations were seeded
at 2 x 105 cells/well, while mixtures of two cell populations were seeded
at 105 cells/well for each cell type, and the cells were treated with respec-
tive stimulus for 6 h. To ascertain heterotypic cell adhesion in mixture
ofdifferent T cellpopulations, cells from populationwere first loaded with
the dye 6 carboxyfluorescein diacetate at 100juM for 1 h at 37°C, washed
extensively, and then mixed with the respective cell type, stimulated for
6 h, and then examined by light and fluorescence microscopy. Similar results
were obtained in one other experiment .
amenable to disruption by mAbs to LFA1 and ICAM-1 as
compared with PMAinduced adhesion. This may relate to
a higher affinity interaction between LFA-1 and ICAM in
cells activated via Ia or due to the involvement ofother adhe-
sion molecules in Ia-mediated adhesion. The critical role of
LFA1 in mediating adhesion induced by Ia-binding ligands
was ascertained by studying a patient whose leukocytes were
severely defective in the expression ofLFA1(<2% of normal)
(14) . Fig . 2 B demonstrates that TSST1 and mAb L243 in-
duced adhesion in normal but not in LFA1-deficient PBMC
preparations enriched in B lymphocytes and in monocytes.
Finally, this cell aggregation was Mgt+ and temperature de-
pendent, typical ofLFA1-mediated adhesion interactions (9)
(data not shown) .
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Figure 4 .
￿
Inhibition of TSST1-, Fab mAb L243-, and PMA-induced
adhesion by sphingosine . Tonsillar human B cells were stimulated in the
absence or in the presence of sphingosine or the sphingosine metabolite
ceramide, which were added as a 1 :1 complex with fatty acid-free BSA .
Results are presented as percent ratio of aggregation observed for each
stimulus in the presenceofsphingosine or ceramidecompared with aggre-
gation observed in the absence of sphingosine or ceramide .
Adhesion induced by Ia-binding ligands was not associated
with upregulation of the surface expression of LFA1 or of
ICAM-1, and did not require protein synthesis, as it was not
affected by cycloheximide, an inhibitor of protein synthesis
(data not shown) . These results suggested that Ia-induced
adhesion is effected by a qualitative change in LFA1 and/or
its counter receptors .
Heterolytic adhesion experiments using primaryT cell lines
derived from normal donors, from the LFA1-deficient pa-
tient, and from the Ia-deficient patient demonstrated that Ia-
induced adhesion was affected by activating LFA1 adhesion
function and not by activating the adhesion function ofLFA1
counter receptors. Fig . 3A demonstrates that mAb L243 failed
to elicit either homotypic or heterolytic aggregates in mix-
tures ofLFA-1-deficient and Ia-deficient activated T cells. In
contrast, PMA induced vigorous heterotypic aggregation in
the same cell mixtures (Fig. 3 B) . Both mAb L243 andPMA
induced heterolytic aggregation in mixtures of Ia+ T cells
and LFA1-deficient cells, and in mixtures of Ia+ T cells and
Ia-deficient T cells (Fig. 3) .
PKC activators may enhance LFA-1 function by inducing
the phosphorylation of LFA1(3 chain (6) or of cytoskeletal
proteins that interact with LFA1, such as talin (15) . To de-
termine the role ofPKC in Ia-mediated adhesion, we exam-
ined the capacity of the PKC inhibitor sphingosine (16) to
antagonize the induction of adhesion by Ia-binding ligands .
Fig. 4A demonstrates that sphingosine inhibited the aggre-
gation oftonsillar B cells induced by TSST1, by mAb L243,
or by PMA . In contrast, the inert sphingosine metabolite
ceramide exhibited no effect on cell aggregation . Other pro-
tein kinase inhibitors such as stauroporine and H7 also in-
hibited cell aggregation (data not shown) . These results sug-
gested that an Ia-coupled protein kinase, either PKC itself
or a closely related enzyme, mediates the induction of adhe-sion via Ia molecules. Otherexperiments established that Ia-
mediated adhesion was not mimicked by activators of
Cal+/calmodulin-dependent or cAMP-dependent protein ki-
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